Tuesday, 02 January 2024 12:17 GMT

Plushcare Launches Enhanced Online Weight Loss Program To Expand National Access To GLP-1 Prescriptions Through Board-Certified Doctors


(MENAFN- GlobeNewsWire - Nasdaq) Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare's Updated Virtual Health Platform

San Francisco, June 10, 2025 (GLOBE NEWSWIRE) --

PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program , enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States.

Accessible at , the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans-all from the comfort of their homes.

Expanded Features for 2025

The revamped Weight Loss Program now includes:

  • Nationwide Access to medical providers via secure telehealth appointments
  • Eligibility Evaluation for FDA-approved medications, including semaglutide
  • Personalized Plans tailored to each user's metabolic profile
  • Optional Lab Testing with integrated results for precision treatment
  • Transparent Pricing with no insurance required

The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery.

Addressing a Growing National Health Concern

According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers.

Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy.

About PlushCare

PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare.

For more information, visit .

Media Contact:
PlushCare Media Relations
Email: ...
Website:
Address: 345 California Street, Suite 600, San Francisco, CA 94105, United States

SOURCE: PlushCare

Disclaimer: This release contains forward-looking statements and should not be considered medical advice. All treatments are subject to clinical evaluation and provider discretion.

CONTACT: Email: ...

MENAFN10062025004107003653ID1109658248


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search